Company profile for Oncovir

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Oncovir, Inc. is a clinical-phase biotechnology company focused on the development of Hiltonol? (Poly ICLC), a potent immunomodulator. Hiltonol? is being advanced both as a therapeutic drug and a vaccine adjuvant for applications in oncology and infectious diseases. Through its dual-action immune-stimulating properties, Hiltonol? holds promise in enhancing vaccine efficacy and improving outcomes in cancer immunotherapy.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3203 Cleveland Avenue NWWashington, DC 20008
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Paris Packaging Week

Paris Packaging Week

Not Confirmed

envelop Contact Supplier

Paris Packaging Week

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty